<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">9216904</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">2419</journal-id>
      <journal-id journal-id-type="nlm-ta">Nat Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat. Genet.</journal-id>
      <journal-title-group>
        <journal-title>Nature genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1061-4036</issn>
      <issn pub-type="epub">1546-1718</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20676099</article-id>
      <article-id pub-id-type="pmc">2930131</article-id>
      <article-id pub-id-type="doi">10.1038/ng.630</article-id>
      <article-id pub-id-type="manuscript">NIHMS216477</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Haploinsufficiency for the erythroid transcription factor KLF1 causes
Hereditary Persistence of Fetal Hemoglobin</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Borg</surname>
            <given-names>Joseph</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Papadopoulos</surname>
            <given-names>Petros</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Georgitsi</surname>
            <given-names>Marianthi</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref rid="FN2" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guti&#xE9;rrez</surname>
            <given-names>Laura</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grech</surname>
            <given-names>Godfrey</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fanis</surname>
            <given-names>Pavlos</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Phylactides</surname>
            <given-names>Marios</given-names>
          </name>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verkerk</surname>
            <given-names>Annemieke J.M.H.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van der Spek</surname>
            <given-names>Peter J.</given-names>
          </name>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scerri</surname>
            <given-names>Christian A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cassar</surname>
            <given-names>Wilhelmina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Galdies</surname>
            <given-names>Ruth</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van IJcken</surname>
            <given-names>Wilfred</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xD6;zg&#xFC;r</surname>
            <given-names>Zeliha</given-names>
          </name>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gillemans</surname>
            <given-names>Nynke</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hou</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bugeja</surname>
            <given-names>Marisa</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grosveld</surname>
            <given-names>Frank G.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A8">8</xref>
          <xref ref-type="aff" rid="A9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>von Lindern</surname>
            <given-names>Marieke</given-names>
          </name>
          <xref ref-type="aff" rid="A10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Felice</surname>
            <given-names>Alex E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref rid="FN1" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Patrinos</surname>
            <given-names>George P.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
          <xref rid="FN1" ref-type="author-notes">#</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Philipsen</surname>
            <given-names>Sjaak</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A8">8</xref>
          <xref rid="FN1" ref-type="author-notes">#</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label> Laboratory of Molecular Genetics, Department of Physiology &amp;
Biochemistry, University of Malta, Msida, MSD 2080, Malta</aff>
      <aff id="A2"><label>2</label> Thalassaemia Clinic, Section of Pathology, Mater Dei Hospital,
Msida, MSD 2080, Malta</aff>
      <aff id="A3"><label>3</label> Erasmus MC, Department of Cell Biology, P.O. Box 2040, 3000 CA
Rotterdam, The Netherlands</aff>
      <aff id="A4"><label>4</label> University of Patras, Department of Pharmacy, University Campus,
Rion GR-265 04, Patras, Greece</aff>
      <aff id="A5"><label>5</label> Cyprus Institute of Neurology and Genetics, P.O. Box 23462, 1683
Nicosia, Cyprus</aff>
      <aff id="A6"><label>6</label> Erasmus MC, Department of Bioinformatics, P.O. Box 2040, 3000 CA
Rotterdam, The Netherlands</aff>
      <aff id="A7"><label>7</label> Erasmus MC, Center for Biomics, P.O. Box 2040, 3000 CA Rotterdam,
The Netherlands</aff>
      <aff id="A8"><label>8</label> Netherlands Consortium for Systems Biology, P.O. Box 2040, 3000 CA
Rotterdam, The Netherlands</aff>
      <aff id="A9"><label>9</label> Center for Biomedical Genetics, P.O. Box 2040, 3000 CA Rotterdam,
The Netherlands</aff>
      <aff id="A10"><label>10</label> Erasmus MC, Department of Hematology, P.O. Box 2040, 3000 CA
Rotterdam, The Netherlands</aff>
      <author-notes>
        <corresp id="FN1"><label>#</label>Corresponding authors:
<email>alex.felice@um.edu.mt</email> (Tel. 356-23402774),
<email>gpatrinos@upatras.gr</email> (Tel. +30-2610-969834),
<email>j.philipsen@erasmusmc.nl</email> (Tel.
+31-10-7044282)</corresp>
        <fn id="FN2" fn-type="equal">
          <label>*</label>
          <p>These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>1</day>
        <month>7</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>8</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>01</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>42</volume>
      <issue>9</issue>
      <fpage>801</fpage>
      <lpage>805</lpage>
      <!--elocation-id from pubmed: 10.1038/ng.630-->
      <permissions>
        <license>
          <license-p>Users may view, print, copy, download and text and data- mine the content in
such documents, for the purposes of academic research, subject always to the
full Conditions of use: <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <p id="P1">Hereditary Persistence of Fetal Hemoglobin (HPFH) is characterized by
persistent high levels of fetal hemoglobin (HbF) in adults. Several contributory
factors, both genetic and environmental, have been identified <xref rid="R1" ref-type="bibr">1</xref>, but others remain elusive. Ten of twenty-seven
members from a Maltese family presented with HPFH. A genome-wide SNP scan
followed by linkage analysis revealed a candidate region on chromosome
19p13.12&#x2013;13. Sequencing identified a nonsense mutation in the
<italic>KLF1</italic> gene, p.K288X, ablating the DNA binding domain of this
key erythroid transcriptional regulator <xref rid="R2" ref-type="bibr">2</xref>.
Only HPFH family members were heterozygote carriers of this mutation. Expression
profiling on primary erythroid progenitors revealed down-regulation of KLF1
target genes in HPFH samples. Functional assays demonstrated that, in addition
to its established role in adult globin expression, KLF1 is a critical activator
of the <italic>BCL11A</italic> gene, encoding a suppressor of HbF expression
<xref rid="R3" ref-type="bibr">3</xref>. These observations provide a
rationale for the effects of <italic>KLF1</italic> haploinsufficiency on HbF
levels.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p id="P2">Hemoglobin (Hb) is composed of two &#x3B1;-like and two &#x3B2;-like globin
chains, encoded by genes in the <italic>HBA</italic> and <italic>HBB</italic> clusters,
respectively. Developmental regulation of globin genes results in expression of
stage-specific Hb variants (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 1</xref>). HbF ameliorates the symptoms of &#x3B2;-thalassemia
and sickle cell disease, and reactivation of the
<italic>HBG1</italic>/<italic>HBG2</italic> genes in adults is therefore of
significant interest for the clinical management of &#x3B2;-type hemoglobinopathies.
After birth, HbF is gradually replaced by adult hemoglobin (HbA) <xref rid="R4" ref-type="bibr">4</xref>. Residual amounts of HbF continue to be synthesized
throughout adult life. In the majority of adults, HbF contributes &lt;2% to
total Hb, but there is considerable variation <xref rid="R5" ref-type="bibr">5</xref>.
Genetic studies have revealed three loci that control HbF levels in adults:
<italic>HBB</italic> (11p15.4) <xref rid="R6" ref-type="bibr">6</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref>, <italic>HBS1L-MYB</italic> (6q23.3) <xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>&#x2013;<xref rid="R9" ref-type="bibr">9</xref> and
<italic>BCL11A</italic> (2p16.1) <xref rid="R10" ref-type="bibr">10</xref>&#x2013;<xref rid="R11" ref-type="bibr">11</xref>. Together, these loci
account for &lt;50% of the variation in HbF, indicating that additional loci are
involved <xref rid="R5" ref-type="bibr">5</xref>. Genetic analysis of HPFH families is a
particularly powerful approach to identify novel modifiers of HbF levels <xref rid="R8" ref-type="bibr">8</xref>. Here, we describe a Maltese pedigree with HPFH. The
proband (II-5, <xref rid="F1" ref-type="fig">Fig. 1a</xref>) was referred to the clinic
because of microcytosis. She presented with high HbF levels (19.5%). Additional
family members were recruited and ten of twenty nine tested were identified with HPFH
(<xref rid="F1" ref-type="fig">Fig. 1a</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>), suggesting an
autosomal dominant inheritance of the trait. Linkage to the <italic>HBB</italic> locus
(<xref rid="SD1" ref-type="supplementary-material">Supplementary methods</xref>) was
excluded, indicating involvement of a <italic>trans</italic>-acting factor. We performed
a genome-wide linkage analysis on twenty seven family members to identify candidate loci
for the HPFH modifier. Whole genome multi-point parametric linkage analysis was
conducted using the Merlin programme <xref rid="R12" ref-type="bibr">12</xref> with two
software packages, easyLINKAGE <xref rid="R13" ref-type="bibr">13</xref> and dChip <xref rid="R14" ref-type="bibr">14</xref>. The analyses resulted in one significant
linkage peak with LOD scores of 2.7 and 4.2, respectively, on chromosome
19p13.12&#x2013;13 (<xref rid="F1" ref-type="fig">Fig. 1b</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2</xref>). These analyses were
performed using an autosomal dominant model, assuming a penetrance of 90% and
1% phenocopy rate. No evidence of significant linkage was observed to the
previously reported <italic>trans</italic>-acting HPFH loci of chromosomes 2p16.1 <xref rid="R10" ref-type="bibr">10</xref>&#x2013;<xref rid="R11" ref-type="bibr">11</xref> and 6q23.3 <xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R8" ref-type="bibr">8</xref>&#x2013;<xref rid="R9" ref-type="bibr">9</xref>. This was
further investigated by genotyping of the five individual SNPs linked to increased HbF
levels. This ruled out involvement of the <italic>HBS1L-MYB</italic> locus and revealed
that heterozygosity at SNP rs766432 in the <italic>BCL11A</italic> locus may have
contributed to the increased HbF levels, but it was not the major determinant (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). HPFH
individuals had a consistent haplotype at 19p13.12&#x2013;13, and the inferred
haplotypes revealed that all HPFH individuals shared one copy of an identical chromosome
segment, presumably containing the putative HPFH locus (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2</xref>). Recombination events
delineating the linkage region are indicated with arrows. The distal boundary is
determined by a recombination event in individuals IV-3 and IV-5 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2</xref>, white arrow). The
proximal boundary is determined by individuals III-12, III-18, IV-6 and IV-7 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2</xref>, black
arrow). These narrowed the region down to a 663 kb interval between rs7247513 and
rs12462609. The <italic>KLF1</italic> gene, encoding a key erythroid transcriptional
regulator <xref rid="R2" ref-type="bibr">2</xref>, resides in this area. Mutations in
<italic>KLF1</italic> have been reported to form the molecular basis of the rare
blood group In(Lu) phenotype <xref rid="R15" ref-type="bibr">15</xref>, but a connection
with HPFH has not been made. DNA sequencing revealed two linked mutations in
<italic>KLF1</italic> present exclusively in all HPFH individuals (<xref rid="F1" ref-type="fig">Fig. 1c</xref>). The first mutation, p.M39L, is most likely a neutral
substitution since mouse Klf1 contains a leucine at this position <xref rid="R16" ref-type="bibr">16</xref>. The second mutation, p.K288X, ablates the complete zinc
finger domain and therefore abrogates DNA binding of the mutant protein <xref rid="R17" ref-type="bibr">17</xref>. The <italic>KLF1</italic> p.K288X variant was absent in a
random sample from the general Maltese population (n=400). To identify
differentially expressed genes, RNA was isolated from erythroid progenitors (HEPs)
cultured from peripheral blood <xref rid="R18" ref-type="bibr">18</xref> of four HPFH
and four non-HPFH family members and used for genome-wide expression analysis.
Comparison to the reported gene expression profiles of mouse Klf1 <italic>null</italic>
erythroid progenitors <xref rid="R19" ref-type="bibr">19</xref> identified a set of
common differentially regulated genes (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). Cluster analysis with this set of genes separated
the non-HPFH samples from the HPFH samples (<xref rid="F2" ref-type="fig">Fig.
2a</xref>), consistent with the notion that KLF1 activity is compromised in the HPFH
individuals. Deregulation of these KLF1 target genes could explain the mild hypochromic
microcytic indices displayed by the HPFH individuals (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). Of note, the
embryonic <italic>Hbb-y</italic> and <italic>HBE1</italic> genes were highly upregulated
(<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>)
while expression of the fetal globin repressor BCL11A <xref rid="R3" ref-type="bibr">3</xref> was downregulated (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3</xref>). Expression of fetal/adult globins can not be measured
quantitatively on the microarrays owing to saturation effects. Quantitative RT-PCR
(qPCR) confirmed downregulation of BCL11A, and showed increased expression of
<italic>HBG1</italic>/<italic>HBG2</italic> genes in the HPFH samples (<xref rid="F2" ref-type="fig">Fig. 2b</xref>). Next, we investigated the effects of KLF1
knockdown in HEPs derived from healthy donors. Efficient knockdown of KLF1 was observed
with two out of five lentiviral shRNA constructs <xref rid="R20" ref-type="bibr">20</xref> tested (<xref rid="F3" ref-type="fig">Fig. 3a</xref>). Quantitative S1
nuclease protection assays <xref rid="R21" ref-type="bibr">21</xref> demonstrated
significantly increased HBG1/HBG2 expression upon KLF1 knockdown (<xref rid="F3" ref-type="fig">Fig. 3b&#x2013;d</xref>), which was confirmed by qPCR (<xref rid="F3" ref-type="fig">Fig. 3e</xref>). In addition, we found that BCL11A
expression was diminished after KLF1 knockdown, both at the protein- (<xref rid="F3" ref-type="fig">Fig. 3a</xref>) and at the mRNA level (<xref rid="F3" ref-type="fig">Fig. 3e</xref>). Thus, the effects of KLF1 insufficiency on HBG1/HBG2 and BCL11A
expression in HEPs from healthy donors were similar to those observed in
<italic>KLF1</italic> p.K288X heterozygotes, supporting the causative role of this
mutation in the HPFH phenotype. To further investigate this, we transduced HEPs with
lentiviral vectors expressing the KLF1 p.K288X truncation mutant or full length KLF1.
The transgenic proteins were expressed at physiological levels in control HEPs (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 4a</xref>). This did
not affect HBG1/HBG2 expression levels (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 4b, c</xref>), indicating that
the truncated form of KLF1 does not act as a dominant-negative factor. In HPFH HEPs,
lentivirus-mediated expression of full-length KLF1 resulted in considerable
downregulation of HBG1/HBG2 mRNA levels, while expression of truncated KLF1 had no
effect (<xref rid="F4" ref-type="fig">Fig. 4</xref>). BCL11A protein levels were
increased after transduction with full-length KLF1 lentivirus, while no such changes
were observed upon transduction with either GFP- or truncated KLF1 lentiviral vectors
(<xref rid="F4" ref-type="fig">Fig. 4a</xref>). We noted that the endogenous
truncated KLF1 protein was not or at best barely detectable in HPFH HEPs. This suggested
that RNA transcribed from the <italic>KLF1</italic> p.K288X allele was subject to
nonsense-mediated decay <xref rid="R22" ref-type="bibr">22</xref>, further emphasizing
that it was dysfunctional. Consistent with this notion, we found that KLF1 mRNA
expression was reduced in HPFH HEPs (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3</xref>). It is well established that KLF1 preferentially
activates the <italic>HBB</italic> gene, at the expense of <italic>HBG1/HBG2</italic>
gene expression, through direct interactions with regulatory elements in the
<italic>HBB</italic> promoter <xref rid="R23" ref-type="bibr">23</xref>&#x2013;<xref rid="R25" ref-type="bibr">25</xref>. The molecular analysis
of the Maltese HPFH family is consistent with this function of KLF1. In addition, it
revealed a novel mechanism by which KLF1 tips the balance from
<italic>HBG1/HBG2</italic> to <italic>HBB</italic> expression: through activation of
the gene encoding the <italic>HBG1/HBG2</italic> repressor BCL11A <xref rid="R3" ref-type="bibr">3</xref>. The promoter area of the <italic>BCL11A</italic> gene
contains several putative KLF1 binding sites (CACC boxes; <xref rid="F5" ref-type="fig">Fig. 5a</xref>). We performed chromatin immunoprecipitation (ChIP) assays to
investigate whether KLF1 was bound to the <italic>BCL11A</italic> promoter <italic>in
vivo</italic>. We used human fetal liver erythroid progenitors, which express high
levels of HBG1/HBG2, and HEPs from adult peripheral blood in which the
<italic>HBG1/HBG2</italic> genes are suppressed. In adult HEPs, we observed strong
binding of KLF1 to the <italic>BCL11A</italic> promoter (<xref rid="F5" ref-type="fig">Fig. 5b</xref>). This was similar to the binding of KLF1 to the
<italic>HBB</italic> promoter which served as a positive control <xref rid="R26" ref-type="bibr">26</xref>. Neither promoter appeared to be bound by KLF1 in fetal
liver-derived erythroid progenitors. ChIP reactions with the unrelated CD71 antibody
were negative in all cases. We conclude that in adult HEPs KLF1 is bound to the
<italic>BCL11A</italic> promoter <italic>in vivo</italic>. Diminished KLF1 activity,
either through mutation of one <italic>KLF1</italic> allele as occurs in the Maltese
HPFH individuals or experimentally through shRNA-mediated knockdown in HEPs from normal
donors, decreased <italic>BCL11A</italic> expression. Conversely, BCL11A levels
increased upon restoration of KLF1 activity in Maltese HPFH HEPs. This identifies KLF1
as a double-barreled regulator of fetal-to-adult globin switching in humans (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 5</xref>). Firstly,
it acts on the <italic>HBB</italic> locus as a preferential activator of the
<italic>HBB</italic> gene <xref rid="R27" ref-type="bibr">27</xref>. Secondly, it
activates expression of <italic>BCL11A</italic>, which in turn represses the
<italic>HBG1/HBG2</italic> genes. This &#x201C;double whammy&#x201D; ensures that
in most adults HbF levels are &lt;2% of total Hb. In conclusion, we have
identified haploinsufficiency for KLF1 as a cause of HPFH. We suggest that attenuation
of KLF1 activity may be a fruitful approach to raise HbF levels in patients with
&#x3B2;-type hemoglobinopathies.</p>
    <sec id="S1">
      <title>Online Methods</title>
      <sec id="S2">
        <title>Molecular genetic analysis</title>
        <p id="P3">The proband (II-5; <xref rid="F1" ref-type="fig">Fig. 1a</xref>) was
referred to the clinic because of microcytosis. She presented with 19.5%
HbF, and therefore additional family members were approached to participate.
Blood samples were obtained with informed consent and standard hematological
indices were determined (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). Genomic DNA was extracted from ~1 &#xD7;
10<sup>6</sup> cells from whole blood using a modified salting out procedure
<xref rid="R29" ref-type="bibr">29</xref>. Control DNA samples isolated from
400 random Maltese individuals were available from the Laboratory of Molecular
Genetics, Biomedical Sciences Building, University of Malta. The family members
were genotyped in the <italic>HBB</italic>, <italic>HBD</italic> genes and the
<italic>HBG1/HBG2</italic> gene promoters to detect point mutations and
small insertions/deletions leading to &#x3B2;-, &#x3B4;-thalassemia or HPFH,
respectively, following routine procedures <xref rid="R30" ref-type="bibr">30</xref>. Gap PCR was carried out to detect possible genomic
rearrangements leading to deletional HPFH or &#x3B4; &#x3B2;-thalassemia
<xref rid="R31" ref-type="bibr">31</xref>. This excluded linkage of the HPFH
phenotype to the <italic>HBB</italic> locus. Occurrence of common
&#x3B1;-thalassemic mutations (SEA, 3.7 and 4.2 deletions) was also excluded.
The <italic>Nsp</italic>I mapping 250K set (Affymetrix, Santa Clara, CA, USA)
was used to analyze twenty seven DNA samples from the HPFH family, starting with
250 ng of genomic DNA per array. Individual SNPs in the
<italic>HBS1L-MYB</italic> (rs28384513, rs9399137, rs4895441) and
<italic>BCL11A</italic> (rs766432, rs11886868) loci <xref rid="R32" ref-type="bibr">32</xref> were genotyped manually.</p>
      </sec>
      <sec id="S3">
        <title>DNA Linkage Analysis</title>
        <p id="P4">Multipoint parametric linkage analyses was performed using the Merlin
v1.0.1 <xref rid="R12" ref-type="bibr">12</xref> program with two software
packages; EasyLinkage v5.05 Beta <xref rid="R13" ref-type="bibr">13</xref> and
dChip <xref rid="R14" ref-type="bibr">14</xref>, in order to calculate
parametric LOD scores. Parametric analysis was carried out using an autosomal
dominant mode of inheritance. Penetrances used for the dominant model were 0.01,
0.90 and 0.90 for the wild-type homozygote, mutant heterozygote and mutant
homozygote, respectively. We assumed a disease allele prevalence frequency of
0.0001, and a phenocopy rate of 1%. A co-dominant allele frequency
algorithm was used for the analysis. These analyses were carried out using the
sex-averaged 500K Marshfield genetic map provided with the easyLINKAGE software
package <xref rid="R13" ref-type="bibr">13</xref>. Mendelian inheritance check
was performed for all family members, using the program PedCheck <xref rid="R33" ref-type="bibr">33</xref> and incompatibilities were omitted from the
analysis. This increased the power and accuracy. The analysis was performed by
taking HbF as a quantitative hematological value and classifying family members
as &#x2018;affected&#x2019; with HbF &gt;2%, and
&#x2018;non-affected&#x2019; with HbF &lt;2%. Replicates of the
linkage analysis and inferred haplotypes were constructed and visualized using
dChip <xref rid="R14" ref-type="bibr">14</xref>. DNA from 400 random Maltese
individuals was used to check for the presence of the KLF1 p.K288X mutation in
the population.</p>
      </sec>
      <sec id="S4">
        <title>Cell culture</title>
        <p id="P5">Human erythroid progenitor cells (HEPs) were cultured as described <xref rid="R18" ref-type="bibr">18</xref> in the presence of recombinant human Epo
(1 unit/ml, kind gift of Ortho-Biotech, Tilburg, The Netherlands), recombinant
human SCF (50 ng/ml, kind gift of Amgen, Breda, The Netherlands) and
dexamethasone (5 &#xD7; 10<sup>&#x2212;7</sup> M; Sigma, St. Louis, MO,
USA). Cells were counted with an electronic cell counter (CASY-1,
Sch&#xE4;rfe System, Reutlingen, Germany).</p>
      </sec>
      <sec id="S5">
        <title>Transcription profiling</title>
        <p id="P6">A minimum of 1.5 &#xD7; 10<sup>6</sup> HEPs were harvested at day12 of
culture and RNA was extracted with Trizol reagent (Sigma) and purified using the
RNeasy Mini Kit (Qiagen, Crawley, UK), including an on-column DNaseI digestion,
according to the manufacturer&#x2019;s instructions. RNA yield was determined
using the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA).
8&#x2013;10&#x3BC;g of total RNA was analysed by microarrays using cells from
day 12 of culture. Quality of the total RNA samples and the resulting cRNA was
assessed on the Bioanalyzer. Fragmented biotinylated cRNA was prepared and
15&#x3BC;g hybridized to HG-U133 plus 2 GeneChips, according to the
manufacturer&#x2019;s protocols (Affymetrix). The data files have been
deposited in MIAME-compliant format in the NCBI GEO database (GSE22109). Single
Array Expression Analysis was performed using the Affymetrix GeneChip Operating
Software (GCOS). A global scaling strategy was used to give an average target
intensity of 500 for each array. Data from all eight arrays were filtered to
exclude probe sets called either absent or marginal in all arrays. Control probe
sets with the prefix AFFX were also removed prior to subsequent data analysis.
Filtered data were transformed to a log2 scale and analysed to determine
differentially expressed genes. A 1.5-fold change threshold and test statistic
of p&lt;0.05 were used as cut-off. A list of genes differentially expressed in
mouse <italic>Klf1</italic> null erythroid progenitors (p&lt;0.05) 19 was
downloaded from <ext-link ext-link-type="uri" xlink:href="http://data.genome.duke.edu/EKLFDef">http://data.genome.duke.edu/EKLFDef</ext-link>.</p>
      </sec>
      <sec id="S6">
        <title>Quantitative S1 nuclease protection assays</title>
        <p id="P7">To measure globin mRNA levels directly, we used quantitative S1 nuclease
protection assays <xref rid="R21" ref-type="bibr">21</xref>. The probe fragment
for detection of HBG1/HBG2 mRNAs was amplified by PCR using the primers S1-HBG-S
and S1-HBG-A (<xref rid="SD1" ref-type="supplementary-material">Supplementary
Table 3</xref>). Sizes of probes/protected fragments are: HBA1/HBA2: 700
nt/218 nt; HBG1/HBG2: 350 nt/165 nt; HBB: 525 nt/155 nt <xref rid="R21" ref-type="bibr">21</xref>. Quantitation was performed using a Typhoon Trio
Phosphorimager (GE Healthcare, Chalfont St Giles, UK) and corrected for specific
activity of the probes.</p>
      </sec>
      <sec id="S7">
        <title>qPCR analysis</title>
        <p id="P8">Total RNA (1 &#x3BC;g) isolated from HEPs was converted to cDNA using
SuperScript II reverse transcriptase according to the manufacturer&#x2019;s
instructions (Invitrogen, Carlsbad, CA, USA). Expression levels of mRNAs were
analysed by quantitative real-time PCR (qPCR). Amplification reactions were
performed with primers designed with Primer Express software v2.0 (Applied
Biosystems, Foster City, CA, USA). All amplifications used SYBR Green PCR Master
Mix (Applied Biosystems). qPCR was performed with an Optical IQ Thermal Cycler
(Bio-Rad Laboratories, Hercules, CA, USA) with the following conditions:
50&#xB0;C for 2 minutes and 95&#xB0;C for 10 minutes, followed by 45
cycles of 95&#xB0;C for 15 seconds and 62&#xB0;C for 45 seconds. All
reactions were performed in triplicate. Gene expression levels were calculated
with the 2 (&#x2212;DeltaDeltaC(T)) method <xref rid="R34" ref-type="bibr">34</xref>. Target gene expression was normalized to GAPDH expression,
unless indicated otherwise. Primers used are listed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>.</p>
      </sec>
      <sec id="S8">
        <title>Statistical analysis</title>
        <p id="P9">Statistical analysis of gene expression data obtained from quantitative
S1 nuclease protection assays and qPCRs was performed with Mann Whitney tests
using STATA data analysis and statistical software (StataCorp LP, College
Station, TX, USA).</p>
      </sec>
      <sec id="S9">
        <title>KLF1 expression constructs</title>
        <p id="P10">Human KLF1 cDNA clone (BC040000, Imagenes, Berlin, Germany) was
amplified by PCR with an <italic>att</italic>-specific set of primers
(Invitrogen) in order to fuse the cDNA with a V5 tag at the C-terminus of the
protein. Primers used were KLF1-F and KLF1-R1 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>). In
parallel, part of the clone was amplified, truncating the protein at amino acid
288, with <italic>att-</italic>specific primers using a different reverse primer
KLF1-R2. The PCR products were introduced into the lentiviral expression vector
pRRLsin.sPPT.CMV.Wpre <xref rid="R35" ref-type="bibr">35</xref> modified for
Gateway cloning (Invitrogen). The final clones were verified by sequencing.</p>
      </sec>
      <sec id="S10">
        <title>Lentiviral transduction of human erythroid progenitors</title>
        <p id="P11">Lentivirus was produced by transient transfection of 293T cells
according to standard protocols <xref rid="R36" ref-type="bibr">36</xref>. Two
days after transfection, the supernatant was collected, filtered and
concentrated by centrifugation at 20 krpm for 2h at 4&#xB0;C. HEPs cultured
for one week were transduced in 24 well plates. We used
0.5&#xD7;10<sup>6</sup> cells per well and sufficient amounts of virus to
transduce ~80% of the cells. When appropriate, puromycin (1&#x3BC;g/ml
final concentration) was added to the cells after 2 days, and selection was
performed for 2&#x2013;3 days. At day 5&#x2013;7 after transduction cells were
harvested and nuclear extracts were prepared <xref rid="R37" ref-type="bibr">37</xref>. RNA was extracted with the Trizol reagent. For knockdown
experiments, clones from The RNAi Consortium (TRC <xref rid="R20" ref-type="bibr">20</xref>; Sigma) were used. The non-target SHC002 vector
was used as a control. (SHC002: 5&#x2019;-CAACAAGATGAAGAGCACCAA-3&#x2019;).
Five shRNA clones targeting KLF1 were tested: TRCN0000016273, TRCN0000016274,
TRCN0000016275, TRCN0000016276 and TRCN0000016277. Efficient knockdown of KLF1
expression was observed with TRCN0000016276 (sh1) and TRCN0000016277 (sh2).
Sequences are listed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>.</p>
      </sec>
      <sec id="S11">
        <title>Western blotting</title>
        <p id="P12">Nuclear extracts were separated on denaturing polyacrylamide gels
followed by semi-dry blotting to PVDF or nitrocellulose membranes. The membranes
were probed with the following primary antibodies: BCL11A (sc-56013, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), NPM1 (ab10530, Abcam, Cambridge, UK), KLF1
<xref rid="R26" ref-type="bibr">26</xref>, and anti-V5-HRP (R961-25,
Invitrogen). For detection, the appropriate secondary antibodies were used. The
enhanced chemoluminescence kit (GE Healthcare) or the Odyssey Infrared Imaging
System (Li-Cor Biosciences, Lincoln, NE, USA) was used to develop the
membranes.</p>
      </sec>
      <sec id="S12">
        <title>Chromatin immunoprecipitations</title>
        <p id="P13">Fetal liver and adult HEPs were cultured <xref rid="R18" ref-type="bibr">18</xref> and used for ChIP reactions were performed as described <xref rid="R38" ref-type="bibr">38</xref> with the KLF1 antibody, and a CD71
antibody (347510, BD Biosciences, San Jose, CA, USA) as a negative control. qPCR
was performed on the input and immuno-precipitated samples using primers for the
<italic>RASSF1A</italic>, <italic>HBB</italic> and <italic>BCL11A</italic>
genes. The relative fold enrichment was calculated as 2<sup>&#x2212;
[(CT x ChIP y &#x2013; CT input y)-(CT KLF1-ChIP HEP RASSF1A- CT
input HEP RASSF1A]</sup> (where &#x2018;x&#x2019; is the antibody
and &#x2018;y&#x2019; the sample), i.e. setting the relative fold-enrichment
of the <italic>RASSF1A</italic> amplicon by the KLF1 antibody in HEPs to 1.
Primers used are listed in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material" id="S13">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>1</label>
        <media xlink:href="NIHMS216477-supplement-1.pdf" mimetype="application" mime-subtype="pdf" xlink:type="simple" id="d37e921" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S15">
      <p>We are grateful to the familymembers for their co-operation. We thank Mr. Teus van
Gent for help with statistical analysis, Dr. Thamar van Dijk for sharing his
expertise in lentiviral technology, Ms. Natalie Papazian for preparation of human
fetal liver samples and Ms. Monica Pizzuto for administrative support. The
population samples from Malta were obtained from the Malta BioBank (EuroBioBank).
This work was supported by institutional funds of the University of Malta and Mater
Dei Hospital to AEF; a Malta Government Scholarship to JB; European Molecular
Biology Organization (EMBO) short-term fellowships to JB and PP; the Netherlands
Scientific Organization (NWO) to LG (VENI 863.09.012); the Netherlands Genomics
Initiative (NGI), Erasmus MC (MRace; 296088), the Landsteiner Foundation for Blood
Transfusion Research (LSBR; 0615), and NWO (DN 82-294 and 912-07-019) to SP; the
Centre for Biomedical Genetics (CBG), the European Commission FP6 EuTRACC consortium
(037445) and the NIH (R01-HL073455) to FG; and the Research Promotion Foundation of
Cyprus (&#x3C0;&#x394; E046_02) and the European Commission FP7 GEN2PHEN
(200754) projects to GPP.</p>
    </ack>
    <fn-group>
      <fn id="FN3" fn-type="con">
        <p>
<bold>AUTHOR CONTRIBUTIONS</bold>
</p>
        <p>FGG, AEF, GPP and SP designed experiments; JB, PP, MG, LG, GG, PF, MP, CAS, WC,
RG, Z&#xD6;, NG, and ML performed experiments; JB, PP, MG, LG and GG analyzed
experiments; PJS FGG, AEF, GPP and SP supervised data analysis, PJS, WIJ and MB,
provided expertise, analysis tools and infrastructure; AJMHV, JH and MB analyzed
data; JB, PP, MG, FGG, ML, AEF, GPP and SP wrote the paper.</p>
      </fn>
      <fn id="FN4" fn-type="conflict">
        <p>
<bold>Declaration of competing financial interests</bold>
</p>
        <p>The authors declare no competing financial interests.</p>
      </fn>
      <fn id="FN5">
        <p>
<bold>Database accession number</bold>
</p>
        <p>GSE22109</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Serjeant</surname><given-names>G</given-names></name></person-group>
<person-group person-group-type="editor"><name><surname>Steinberg</surname><given-names>MH</given-names></name><name><surname>Forget</surname><given-names>BG</given-names></name><name><surname>Higgs</surname><given-names>DR</given-names></name><name><surname>Nagel</surname><given-names>RL</given-names></name></person-group>
<article-title>Geographic heterogeneity of sickle cell disease</article-title>
<source>Disorders of Hemoglobin</source>
<fpage>895</fpage>
<lpage>906</lpage>
<publisher-name>Cambridge University Press</publisher-name>
<publisher-loc>Cambrige</publisher-loc>
<year>2001</year>
</element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bieker</surname><given-names>JJ</given-names></name></person-group>
<article-title>Probing the onset and regulation of erythroid cell-specific gene
expression</article-title>
<source>Mt Sinai J Med</source>
<volume>72</volume>
<fpage>333</fpage>
<lpage>8</lpage>
<year>2005</year>
<pub-id pub-id-type="pmid">16184297</pub-id></element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sankaran</surname><given-names>VG</given-names></name><etal/></person-group>
<article-title>Human fetal hemoglobin expression is regulated by the
developmental stage-specific repressor BCL11A</article-title>
<source>Science</source>
<volume>322</volume>
<fpage>1839</fpage>
<lpage>42</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">19056937</pub-id></element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Stamatoyannopoulos</surname><given-names>G</given-names></name><name><surname>Grosveld</surname><given-names>F</given-names></name></person-group>
<person-group person-group-type="editor"><name><surname>Stamatoyannopoulos</surname><given-names>G</given-names></name><name><surname>Majerus</surname><given-names>PW</given-names></name><name><surname>Perlmutter</surname><given-names>RM</given-names></name><name><surname>Varmus</surname><given-names>H</given-names></name></person-group>
<article-title>Hemoglobin switching</article-title>
<source>The Molecular Basis of Blood Diseases</source>
<fpage>135</fpage>
<lpage>182</lpage>
<publisher-name>WB Saunders Company</publisher-name>
<publisher-loc>Philadelphia PA</publisher-loc>
<year>2001</year>
</element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thein</surname><given-names>SL</given-names></name><name><surname>Menzel</surname><given-names>S</given-names></name><name><surname>Lathrop</surname><given-names>M</given-names></name><name><surname>Garner</surname><given-names>C</given-names></name></person-group>
<article-title>Control of fetal hemoglobin: new insights emerging from genomics
and clinical implications</article-title>
<source>Hum Mol Genet</source>
<volume>18</volume>
<fpage>R216</fpage>
<lpage>23</lpage>
<year>2009</year>
<pub-id pub-id-type="pmid">19808799</pub-id></element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Craig</surname><given-names>JE</given-names></name><etal/></person-group>
<article-title>Dissecting the loci controlling fetal haemoglobin production on
chromosomes 11p and 6q by the regressive approach</article-title>
<source>Nat Genet</source>
<volume>12</volume>
<fpage>58</fpage>
<lpage>64</lpage>
<year>1996</year>
<pub-id pub-id-type="pmid">8528252</pub-id></element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilman</surname><given-names>JG</given-names></name><name><surname>Huisman</surname><given-names>TH</given-names></name></person-group>
<article-title>DNA sequence variation associated with elevated fetal G gamma
globin production</article-title>
<source>Blood</source>
<volume>66</volume>
<fpage>783</fpage>
<lpage>7</lpage>
<year>1985</year>
<pub-id pub-id-type="pmid">2412616</pub-id></element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Close</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Genome annotation of a 1.5 Mb region of human chromosome 6q23
encompassing a quantitative trait locus for fetal hemoglobin expression in
adults</article-title>
<source>BMC Genomics</source>
<volume>5</volume>
<fpage>33</fpage>
<year>2004</year>
<pub-id pub-id-type="pmid">15169551</pub-id></element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garner</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Haplotype mapping of a major quantitative-trait locus for fetal
hemoglobin production, on chromosome 6q23</article-title>
<source>Am J Hum Genet</source>
<volume>62</volume>
<fpage>1468</fpage>
<lpage>74</lpage>
<year>1998</year>
<pub-id pub-id-type="pmid">9585587</pub-id></element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lettre</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci
associate with fetal hemoglobin levels and pain crises in sickle cell
disease</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>
<fpage>11869</fpage>
<lpage>74</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18667698</pub-id></element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Menzel</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>A QTL influencing F cell production maps to a gene encoding a
zinc-finger protein on chromosome 2p15</article-title>
<source>Nat Genet</source>
<volume>39</volume>
<fpage>1197</fpage>
<lpage>9</lpage>
<year>2007</year>
<pub-id pub-id-type="pmid">17767159</pub-id></element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name></person-group>
<article-title>Merlin--rapid analysis of dense genetic maps using sparse gene
flow trees</article-title>
<source>Nat Genet</source>
<volume>30</volume>
<fpage>97</fpage>
<lpage>101</lpage>
<year>2002</year>
<pub-id pub-id-type="pmid">11731797</pub-id></element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Lindner</surname><given-names>TH</given-names></name></person-group>
<article-title>easyLINKAGE-Plus--automated linkage analyses using large-scale
SNP data</article-title>
<source>Bioinformatics</source>
<volume>21</volume>
<fpage>3565</fpage>
<lpage>7</lpage>
<year>2005</year>
<pub-id pub-id-type="pmid">16014370</pub-id></element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leykin</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Comparative linkage analysis and visualization of high-density
oligonucleotide SNP array data</article-title>
<source>BMC Genet</source>
<volume>6</volume>
<fpage>7</fpage>
<year>2005</year>
<pub-id pub-id-type="pmid">15713228</pub-id></element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singleton</surname><given-names>BK</given-names></name><name><surname>Burton</surname><given-names>NM</given-names></name><name><surname>Green</surname><given-names>C</given-names></name><name><surname>Brady</surname><given-names>RL</given-names></name><name><surname>Anstee</surname><given-names>DJ</given-names></name></person-group>
<article-title>Mutations in EKLF/KLF1 form the molecular basis of the rare blood
group In(Lu) phenotype</article-title>
<source>Blood</source>
<volume>112</volume>
<fpage>2081</fpage>
<lpage>8</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18487511</pub-id></element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>IJ</given-names></name><name><surname>Bieker</surname><given-names>JJ</given-names></name></person-group>
<article-title>A novel, erythroid cell-specific murine transcription factor that
binds to the CACCC element and is related to the Kruppel family of nuclear
proteins</article-title>
<source>Mol Cell Biol</source>
<volume>13</volume>
<fpage>2776</fpage>
<lpage>86</lpage>
<year>1993</year>
<pub-id pub-id-type="pmid">7682653</pub-id></element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feng</surname><given-names>WC</given-names></name><name><surname>Southwood</surname><given-names>CM</given-names></name><name><surname>Bieker</surname><given-names>JJ</given-names></name></person-group>
<article-title>Analyses of beta-thalassemia mutant DNA interactions with
erythroid Kruppel-like factor (EKLF), an erythroid cell-specific
transcription factor</article-title>
<source>J Biol Chem</source>
<volume>269</volume>
<fpage>1493</fpage>
<lpage>500</lpage>
<year>1994</year>
<pub-id pub-id-type="pmid">8288615</pub-id></element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leberbauer</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Different steroids co-regulate long-term expansion versus
terminal differentiation in primary human erythroid
progenitors</article-title>
<source>Blood</source>
<volume>105</volume>
<fpage>85</fpage>
<lpage>94</lpage>
<year>2005</year>
<pub-id pub-id-type="pmid">15358620</pub-id></element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pilon</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Failure of terminal erythroid differentiation in EKLF-deficient
mice is associated with cell cycle perturbation and reduced expression of
E2F2</article-title>
<source>Mol Cell Biol</source>
<volume>28</volume>
<fpage>7394</fpage>
<lpage>401</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18852285</pub-id></element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moffat</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>A lentiviral RNAi library for human and mouse genes applied to an
arrayed viral high-content screen</article-title>
<source>Cell</source>
<volume>124</volume>
<fpage>1283</fpage>
<lpage>98</lpage>
<year>2006</year>
<pub-id pub-id-type="pmid">16564017</pub-id></element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antoniou</surname><given-names>M</given-names></name></person-group>
<article-title>Induction of erythroid-specific expression in murine
erythroleukemia (MEL) cell lines</article-title>
<source>Methods in Molecular Biology</source>
<volume>7</volume>
<fpage>421</fpage>
<lpage>434</lpage>
<year>1991</year>
<pub-id pub-id-type="pmid">21416373</pub-id></element-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muhlemann</surname><given-names>O</given-names></name><name><surname>Eberle</surname><given-names>AB</given-names></name><name><surname>Stalder</surname><given-names>L</given-names></name><name><surname>Zamudio Orozco</surname><given-names>R</given-names></name></person-group>
<article-title>Recognition and elimination of nonsense mRNA</article-title>
<source>Biochim Biophys Acta</source>
<volume>1779</volume>
<fpage>538</fpage>
<lpage>49</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18657639</pub-id></element-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Donze</surname><given-names>D</given-names></name><name><surname>Townes</surname><given-names>TM</given-names></name><name><surname>Bieker</surname><given-names>JJ</given-names></name></person-group>
<article-title>Role of erythroid Kruppel-like factor in human gamma- to
beta-globin gene switching</article-title>
<source>J Biol Chem</source>
<volume>270</volume>
<fpage>1955</fpage>
<lpage>9</lpage>
<year>1995</year>
<pub-id pub-id-type="pmid">7829533</pub-id></element-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drissen</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The active spatial organization of the beta-globin locus requires
the transcription factor EKLF</article-title>
<source>Genes Dev</source>
<volume>18</volume>
<fpage>2485</fpage>
<lpage>90</lpage>
<year>2004</year>
<pub-id pub-id-type="pmid">15489291</pub-id></element-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Pawlik</surname><given-names>KM</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>CW</given-names></name><name><surname>Townes</surname><given-names>TM</given-names></name></person-group>
<article-title>Differential binding of erythroid Krupple-like factor to
embryonic/fetal globin gene promoters during development</article-title>
<source>J Biol Chem</source>
<volume>281</volume>
<fpage>16052</fpage>
<lpage>7</lpage>
<year>2006</year>
<pub-id pub-id-type="pmid">16606611</pub-id></element-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bottardi</surname><given-names>S</given-names></name><name><surname>Ross</surname><given-names>J</given-names></name><name><surname>Pierre-Charles</surname><given-names>N</given-names></name><name><surname>Blank</surname><given-names>V</given-names></name><name><surname>Milot</surname><given-names>E</given-names></name></person-group>
<article-title>Lineage-specific activators affect beta-globin locus chromatin in
multipotent hematopoietic progenitors</article-title>
<source>EMBO J</source>
<volume>25</volume>
<fpage>3586</fpage>
<lpage>95</lpage>
<year>2006</year>
<pub-id pub-id-type="pmid">16858401</pub-id></element-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wijgerde</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The role of EKLF in human beta-globin gene
competition</article-title>
<source>Genes Dev</source>
<volume>10</volume>
<fpage>2894</fpage>
<lpage>902</lpage>
<year>1996</year>
<pub-id pub-id-type="pmid">8918890</pub-id></element-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Drissen</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>The erythroid phenotype of EKLF-null mice: defects in hemoglobin
metabolism and membrane stability</article-title>
<source>Mol Cell Biol</source>
<volume>25</volume>
<fpage>5205</fpage>
<lpage>14</lpage>
<year>2005</year>
<pub-id pub-id-type="pmid">15923635</pub-id></element-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>SA</given-names></name><name><surname>Dykes</surname><given-names>DD</given-names></name><name><surname>Polesky</surname><given-names>HF</given-names></name></person-group>
<article-title>A simple salting out procedure for extracting DNA from human
nucleated cells</article-title>
<source>Nucleic Acids Res</source>
<volume>16</volume>
<fpage>1215</fpage>
<year>1988</year>
<pub-id pub-id-type="pmid">3344216</pub-id></element-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trifillis</surname><given-names>P</given-names></name><name><surname>Ioannou</surname><given-names>P</given-names></name><name><surname>Schwartz</surname><given-names>E</given-names></name><name><surname>Surrey</surname><given-names>S</given-names></name></person-group>
<article-title>Identification of four novel delta-globin gene mutations in Greek
Cypriots using polymerase chain reaction and automated fluorescence-based
DNA sequence analysis</article-title>
<source>Blood</source>
<volume>78</volume>
<fpage>3298</fpage>
<lpage>305</lpage>
<year>1991</year>
<pub-id pub-id-type="pmid">1742490</pub-id></element-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Craig</surname><given-names>JE</given-names></name><name><surname>Barnetson</surname><given-names>RA</given-names></name><name><surname>Prior</surname><given-names>J</given-names></name><name><surname>Raven</surname><given-names>JL</given-names></name><name><surname>Thein</surname><given-names>SL</given-names></name></person-group>
<article-title>Rapid detection of deletions causing delta beta thalassemia and
hereditary persistence of fetal hemoglobin by enzymatic
amplification</article-title>
<source>Blood</source>
<volume>83</volume>
<fpage>1673</fpage>
<lpage>82</lpage>
<year>1994</year>
<pub-id pub-id-type="pmid">7510147</pub-id></element-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Higgs</surname><given-names>DR</given-names></name><name><surname>Wood</surname><given-names>WG</given-names></name></person-group>
<article-title>Genetic complexity in sickle cell disease</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>105</volume>
<fpage>11595</fpage>
<lpage>6</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18695233</pub-id></element-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Connell</surname><given-names>JR</given-names></name><name><surname>Weeks</surname><given-names>DE</given-names></name></person-group>
<article-title>PedCheck: a program for identification of genotype
incompatibilities in linkage analysis</article-title>
<source>Am J Hum Genet</source>
<volume>63</volume>
<fpage>259</fpage>
<lpage>66</lpage>
<year>1998</year>
<pub-id pub-id-type="pmid">9634505</pub-id></element-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmittgen</surname><given-names>TD</given-names></name><name><surname>Livak</surname><given-names>KJ</given-names></name></person-group>
<article-title>Analyzing real-time PCR data by the comparative C(T)
method</article-title>
<source>Nat Protoc</source>
<volume>3</volume>
<fpage>1101</fpage>
<lpage>8</lpage>
<year>2008</year>
<pub-id pub-id-type="pmid">18546601</pub-id></element-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Follenzi</surname><given-names>A</given-names></name><name><surname>Sabatino</surname><given-names>G</given-names></name><name><surname>Lombardo</surname><given-names>A</given-names></name><name><surname>Boccaccio</surname><given-names>C</given-names></name><name><surname>Naldini</surname><given-names>L</given-names></name></person-group>
<article-title>Efficient gene delivery and targeted expression to hepatocytes in
vivo by improved lentiviral vectors</article-title>
<source>Hum Gene Ther</source>
<volume>13</volume>
<fpage>243</fpage>
<lpage>60</lpage>
<year>2002</year>
<pub-id pub-id-type="pmid">11812281</pub-id></element-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zufferey</surname><given-names>R</given-names></name><name><surname>Nagy</surname><given-names>D</given-names></name><name><surname>Mandel</surname><given-names>RJ</given-names></name><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Trono</surname><given-names>D</given-names></name></person-group>
<article-title>Multiply attenuated lentiviral vector achieves efficient gene
delivery in vivo</article-title>
<source>Nat Biotechnol</source>
<volume>15</volume>
<fpage>871</fpage>
<lpage>5</lpage>
<year>1997</year>
<pub-id pub-id-type="pmid">9306402</pub-id></element-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andrews</surname><given-names>NC</given-names></name><name><surname>Faller</surname><given-names>DV</given-names></name></person-group>
<article-title>A rapid micropreparation technique for extraction of DNA-binding
proteins from limiting numbers of mammalian cells</article-title>
<source>Nucleic Acids Res</source>
<volume>19</volume>
<fpage>2499</fpage>
<year>1991</year>
<pub-id pub-id-type="pmid">2041787</pub-id></element-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Follows</surname><given-names>GA</given-names></name><etal/></person-group>
<article-title>Epigenetic consequences of AML1-ETO action at the human c-FMS
locus</article-title>
<source>EMBO J</source>
<volume>22</volume>
<fpage>2798</fpage>
<lpage>809</lpage>
<year>2003</year>
<pub-id pub-id-type="pmid">12773394</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Chromosome 19 locus linked to HPFH in a Maltese family</title>
        <p>a) The Maltese HPFH pedigree. HbF levels are indicated as percentage of total
Hb (%HbF). HPFH individuals are shown as half-filled symbols.</p>
        <p>b) LOD scores derived from genome-wide linkage analysis. The putative HPFH
locus on chr. 19 is indicated by an arrow. pLOD = parametric LOD
score; MPT = multi point test; cM = centiMorgan.</p>
        <p>c) Sequence analysis of <italic>KLF1</italic>. HPFH individuals were
heterozygous for two mutations (arrows; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). The
predicted effects of the mutations on KLF1 protein are shown below.</p>
      </caption>
      <graphic xlink:href="nihms216477f1"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <title>KLF1 target genes are downregulated in wt/KLF1 p.K288X HEPs</title>
        <p>a) RNA isolated from HEPs derived from normal (wt/wt) and HPFH (wt/KLF1
p.K288X) family members was used for genome-wide expression analysis.
Deregulated genes common between wt/wt and wt/KLF1 p.K288X and mouse wt/wt
versus <italic>Klf1</italic> null mutant erythroid progenitors <xref rid="R19" ref-type="bibr">19</xref> (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>) were
used for cluster analysis.</p>
        <p>b) Validation of key target genes by qPCR. Expression levels of BCL11A were
normalized using GAPDH as a reference. Expression levels of HBG1/HBG2 (HBG)
were calculated as ratio to HBA1/HBA2 (HBA) expression. Medians are
indicated by red lines in the box plots. Asterisk: p=0.0209.</p>
      </caption>
      <graphic xlink:href="nihms216477f2"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Increased HBG1/HBG2 expression after knockdown of KLF1 in normal
HEPs</title>
        <p>a) HEPs derived from normal donors were transduced with shRNA-expressing
lentiviruses. Cells were harvested five days after transduction, and nuclear
extracts prepared. Top panels: KLF1 protein expression assessed by Western
blot analysis. Bottom panels: BCL11A protein levels were reduced upon KLF1
knockdown. NPM1 served as a loading control. None = mock
transduction; TRC = control non-specific shRNA; sh1 and sh2
= two independent shRNAs targeting KLF1. A non-specific band is
indicated (&lt;).</p>
        <p>b) RNA was isolated from HEPs five days after transduction with the indicated
lentiviruses, and used in quantitative S1 nuclease protection assays to
measure globin expression. Arrows indicate protected fragments diagnostic
for HBA1/HBA2 (HBA), HBG1/HBG2 (HBG) and HBB mRNAs.</p>
        <p>c) Quantitation of data shown in b) by Phosphorimager analysis.</p>
        <p>d) Box plots of HBG/HBA ratios after sh1-mediated KLF1 knockdown in HEPs
derived from three independent donors. Medians are indicated by red lines.
Asterisk: p=0.0463.</p>
        <p>e) Box plots of qPCR analysis of AHSP, BCL11A and HBG expression after
sh1/sh2-mediated KLF1 knockdown. <italic>AHSP</italic> is a known KLF1
target gene <xref rid="R28" ref-type="bibr">28</xref> and serves as a
positive control. Expression levels of AHSP and BCL11A were normalized using
GAPDH as a reference. Expression levels of HBG were calculated as ratio to
total &#x3B2;-like globin expression (HBG + HBB) expression.
Medians are indicated by red lines. Circles: points outside the range of the
error bars. Asterisk: p=0.020; double asterisks: p&lt;0.003.</p>
      </caption>
      <graphic xlink:href="nihms216477f3"/>
    </fig>
    <fig id="F4" position="float">
      <label>Figure 4</label>
      <caption>
        <title>Expression of exogenous KLF1 in HPFH HEPs</title>
        <p>a) HEPs derived from individual II-5 were transduced with lentiviral
constructs expressing GFP, KLF1 truncated at amino acid 288 (TR) or
full-length KLF1 (FL). Seven days after transduction, nuclear extracts were
prepared and expression of BCL11A and KLF1 was assessed by Western blot.
NPM1 served as a loading control.</p>
        <p>b) RNA was isolated from II-5 HEPs seven days after transduction with the
indicated lentiviruses, and was used for quantitative S1 nuclease protection
assays to measure globin mRNA expression. Arrows indicate protected
fragments diagnostic for HBA1/HBA2 (HBA), HBG1/HBG2 (HBG) and HBB mRNAs.</p>
        <p>c) Quantitation of data shown in b) by Phosphorimager analysis.</p>
      </caption>
      <graphic xlink:href="nihms216477f4"/>
    </fig>
    <fig id="F5" position="float">
      <label>Figure 5</label>
      <caption>
        <title>KLF1 binds to the promoter of the BCL11A gene in vivo</title>
        <p>a) Schematic drawings of the promoter areas of the <italic>BCL11A</italic>,
<italic>HBB</italic> and <italic>RASSF1A</italic> genes. Positions of
potential KLF1 binding sites (CACC boxes) and PCR primers used are
indicated. Arrows indicate transcription start sites.</p>
        <p>b) ChIP analysis of KLF1 binding to the <italic>BCL11A</italic> promoter in
human fetal liver cells and adult HEPs. The <italic>HBB</italic> promoter
served as a positive control <xref rid="R26" ref-type="bibr">26</xref>.
<italic>RASSF1A</italic> was used as a negative control, and the
unrelated CD71 antibody served as a control for the specificity of the KLF1
antibody. Asterisk: p&lt;0.05; double asterisks: p&lt;0.01. Error bars:
standard deviation.</p>
      </caption>
      <graphic xlink:href="nihms216477f5"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
